Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
Reliability assessment of the non-rigid registration for central incisors movement evaluation based on CBCT registration. [PDF]
Wu ZX +10 more
europepmc +1 more source
The Monetary Transmission Mechanism in Chile: A Medium-sized Macroeconomics Model [PDF]
Carlos García +7 more
core
LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix +13 more
wiley +1 more source
Correction: Global burden of disease 2021: particulate matter pollution-attributable burden of upper respiratory infections, otitis media, and lower respiratory infections. [PDF]
Wei C, Tang Y, Wang Y.
europepmc +1 more source
From Planning to Implementation: The New UK Central Government Financial Framework
Andrew Likierman
openalex +2 more sources
Trade Orientation and Labor Market Evolution: Evidence from Chilean Plant-level Data [PDF]
Andrea Tokman R. +5 more
core
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source

